logo

Progenics Pharmaceuticals Inc (PGNX)



Trade PGNX now with
  Date
  Headline
6/22/2020 7:10:03 AM Lantheus Completes Merger With Progenics
6/16/2020 4:11:42 PM Progenics Stockholders Approve Merger With Lantheus
5/18/2020 8:41:21 AM Progenics Says Phase 3 CONDOR Trial Of PyL Meets Primary Endpoint With A Correct Localization Rate Of 84.8–87.0%
5/7/2020 7:49:21 AM Progenics Q1 Loss/Shr $0.19 Vs Loss $0.22 Prior Year
12/23/2019 7:05:09 AM Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial Of PyL In Prostate Cancer Meets Primary Endpoint
10/2/2019 7:10:51 AM Lantheus To Purchase Progenics In An All-stock Transaction
8/5/2019 8:36:34 AM Progenics Pharma Completes Enrollment In Pivotal Phase 3 CONDOR Study Of PyL For Detection Of Prostate Cancer
7/22/2019 8:17:30 AM Velan : Voting Results At Progenics Confirm Two-Thirds Of Votes Cast Against Re-Election Of Peter Crowley And Michael
7/12/2019 9:36:38 AM Progenics Begins Search Process To Identify New Board Candidates
7/8/2019 8:35:26 AM Progenics Urges Shareholders To Vote Today “FOR” The Highly Qualified Director Candidates On The WHITE Proxy Card
7/8/2019 8:04:59 AM Velan Reminds Stockholders To Follow ISS' Recommendation By Voting "Against" Progenics Directors Crowley And Kishbauch
7/8/2019 7:35:35 AM Progenics Appoints Huw Jones To Newly Created Role Of VP, Commercial
7/1/2019 8:03:42 AM Velan Urges Stockholders To Vote "Against" Progenics Directors Peter Crowley And Michael Kishbauch
6/28/2019 12:11:27 AM Velan Clarifies Interactions With Progenics Pharma' Board Of Directors
6/20/2019 8:33:43 AM Progenics Pharma To Initiate Basket Trial By Year End To Support An Expanded Label For AZEDRA
6/20/2019 7:40:37 AM Velan Capital Calls On Progenics' Board To Back Up Recent Claims